Literature DB >> 17350975

Cholinesterase inhibitors and cardiovascular disease: a survey of old age psychiatrists' practice.

Darren M Malone1, James Lindesay.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17350975     DOI: 10.1093/ageing/afm002

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


× No keyword cloud information.
  5 in total

1.  QT interval prolongation and Torsades de Pointes with donepezil, rivastigmine and galantamine.

Authors:  Katie Malone; Jules C Hancox
Journal:  Ther Adv Drug Saf       Date:  2020-08-17

Review 2.  Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

3.  Factors associated with serious adverse reactions to cholinesterase inhibitors: a study of spontaneous reporting.

Authors:  Antoine Pariente; Dina Joseph-Reinette Sanctussy; Ghada Miremont-Salamé; Nicholas Moore; Françoise Haramburu; Annie Fourrier-Réglat
Journal:  CNS Drugs       Date:  2010-01       Impact factor: 5.749

4.  Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.

Authors:  Deguo Wang; Yong Wu; Ancai Wang; Yueyun Chen; Ting Zhang; Nengwei Hu
Journal:  Cardiol Res Pract       Date:  2018-04-23       Impact factor: 1.866

Review 5.  Inflammatory and Infectious Processes Serve as Links between Atrial Fibrillation and Alzheimer's Disease.

Authors:  Gabriela Lopes Martins; Rita Carolina Figueiredo Duarte; Marat A Mukhamedyarov; András Palotás; Cláudia Natália Ferreira; Helton José Reis
Journal:  Int J Mol Sci       Date:  2020-05-02       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.